Trial reportNeural plasticity2026
Surgery versus Botulinum Toxin A for Treatment of Post-Stroke Upper-Limb Spasticity: White Matter Changes, Function, and Quality-of-Life-A Randomized Controlled Trial.
Trial report in Neural plasticity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionA magnetic resonance image (MRI) study recently described greater improvements in gray matter volume and cortical thickness in post-stroke patients with upper-limb spasticity treated with surgery versus botulinum toxin-A (BoNT-A).
objectiveTo compare changes in the white matter of these patients after surgical versus BoNT-A treatment and to relate findings to upper-limb function and quality-of-life.
methodsIn a two-arm randomized controlled clinical trial, 30 post-stroke patients (>12 months) with spastic upper limbs were recruited and randomly assigned (1:1) to surgery or BoNT-A treatment (controls). Functional and quality-of-life parameters were studied at baseline (pre-intervention) and at 6 months, while brain MRI scans of the white matter were taken at the same time points using a Siemens 3T Prisma MRI scanner. Although baseline MRI scans were obtained in all 30 participants, complete longitudinal MRI data were available for only 14 participants because of contraindications or refusal of follow-up imaging. Therefore, the imaging analyses were considered only exploratory and hypothesis-generating.
resultsIncreased post- versus pre-surgery fractional anisotropy (FA) values were associated with Carer Burden and House functional scale scores, and decreased FA values with Ashworth, Fugl-Meyer, pain visual analogue scale, and SF-36 scores. Reduced mean diffusivity (MD) values for inferior fronto-occipital fasciculus, cingulum parahippocampal parietal, uncinate fasciculus, and reticular tract were associated with improvements in Fugl-Meyer motor recovery scores.
conclusionThe post-pre increase in FA of white matter tracts in the experimental versus control group may suggest differences in white matter microstructure between treatment groups, potentially reflecting neuroplastic changes. These findings suggest that changes in white matter microstructure might be associated with improvements in motor function, independence, and caregiver burden. However, given the small longitudinal MRI sample, the tract-specific findings should be considered hypothesis-generating and require confirmation in larger studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.